Skip to main content
. 2020 Feb 6;9(4):e014279. doi: 10.1161/JAHA.119.014279

Table 4.

Linear Regression Analyses for the Longitudinal Association of NAFLD With Prevalent Left Ventricular Function, The CARDIA Study, 2015 to 2016

Y30 Markers of LV Function
LVEF E/A Ratio E/e′ Ratio Longitudinal Strain Cardiac Output
β (SE) P Value β (SE) P Value β (SE) P Value β (SE) P Value β (SE) P Value
Base Model* −1.3 (0.47) 0.006 −0.12 (0.03) <0.0001 0.68 (0.20) 0.0006 1.4 (0.24) <0.0001 0.80 (0.10) <0.0001
Multivariable −1.1 (0.46) 0.02 −0.12 (0.03) <0.0001 0.86 (0.19) <0.0001 1.2 (0.24) <0.0001 0.70 (0.10) <0.0001
+HF risk factors§ −0.96 (0.50) 0.05 −0.07 (0.03) 0.02 0.48 (0.20) 0.02 0.59 (0.25) 0.02 0.50 (0.11) <0.0001
Multivariable +HF RFs+BMI −0.89 (0.50) 0.08 −0.05 (0.03) 0.07 0.41 (0.20) 0.04 0.49 (0.26) 0.06 0.22 (0.10) 0.03
Multivariable +HF RFs+ %change BMI −1.0 (0.50) 0.04 −0.07 (0.001) 0.01 0.50 (0.20) 0.01 0.61 (0.25) 0.02 0.52 (0.11) <0.0001
Multivariable +HF RFs + VAT −0.95 (0.52) 0.07 −0.03 (0.03) 0.34 0.35 (0.21) 0.10 0.41 (0.26) 0.12 0.12 (0.11) 0.30
Multivariable + HF RFs+ BMI + %change BMI −0.02 (0.01) 0.19 −0.003 (0.0009) 0.005 0.10 (0.006) 0.07 0.20 (0.008) 0.08 0.10 (0.003) 0.0005

BMI indicates body mass index; CARDIA, Coronary Artery Risk Development in Young Adults; HF, heart failure; LVEF, left ventricular ejection fraction; NAFLD, non‐alcoholic fatty liver disease; VAT, visceral adipose tissue.

*

Adjusted for center only.

Statistically significant.

Multivariable model: adjusted for age, race, sex, study center, education, income level, alcohol intake (drinks/week), smoking status (current/former vs never), physical activity score.

§

Heart failure risk factors: systolic blood pressure, antihypertensive medication use, anti‐hyperlipidemic medication use, total cholesterol, high‐density lipoprotein cholesterol, diabetes mellitus status, and glomerular filtration rate.

%change BMI=(Y30 BMI−Y25 BMI)/Y25 BMI×100.